These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28159748)

  • 21. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogenic regulation of host immunity against an estrogen receptor-negative human breast cancer.
    Curran EM; Judy BM; Duru NA; Wang HQ; Vergara LA; Lubahn DB; Estes DM
    Clin Cancer Res; 2006 Oct; 12(19):5641-7. PubMed ID: 17000652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coactivation of Estrogen Receptor and IKKβ Induces a Dormant Metastatic Phenotype in ER-Positive Breast Cancer.
    El-Shennawy L; Dubrovskyi O; Kastrati I; Danes JM; Zhang Y; Whiteley HE; Creighton CJ; Frasor J
    Cancer Res; 2018 Feb; 78(4):974-984. PubMed ID: 29229606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of transforming growth factor-beta in the regulation of estrogen receptor expression in the MCF-7 breast cancer cell line.
    Stoica A; Saceda M; Fakhro A; Solomon HB; Fenster BD; Martin MB
    Endocrinology; 1997 Apr; 138(4):1498-505. PubMed ID: 9075708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of interleukin-8 in the progression of estrogen receptor-negative breast cancer.
    Yao C; Lin Y; Ye CS; Bi J; Zhu YF; Wang SM
    Chin Med J (Engl); 2007 Oct; 120(20):1766-72. PubMed ID: 18028768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
    Raha P; Thomas S; Thurn KT; Park J; Munster PN
    Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis.
    Harrell JC; Dye WW; Harvell DM; Pinto M; Jedlicka P; Sartorius CA; Horwitz KB
    Cancer Res; 2007 Nov; 67(21):10582-91. PubMed ID: 17975003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation.
    Masuda H; Otsuka F; Matsumoto Y; Takano M; Miyoshi T; Inagaki K; Shien T; Taira N; Makino H; Doihara H
    Mol Cell Endocrinol; 2011 Aug; 343(1-2):7-17. PubMed ID: 21664418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
    Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K
    Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of constitutively active Akt-3 in MCF-7 breast cancer cells reverses the estrogen and tamoxifen responsivity of these cells in vivo.
    Faridi J; Wang L; Endemann G; Roth RA
    Clin Cancer Res; 2003 Aug; 9(8):2933-9. PubMed ID: 12912939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathobiology of the 129:Stat1
    Mori H; Chen JQ; Cardiff RD; Pénzváltó Z; Hubbard NE; Schuetter L; Hovey RC; Trott JF; Borowsky AD
    Breast Cancer Res; 2017 Sep; 19(1):102. PubMed ID: 28865492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
    Schwarz LJ; Fox EM; Balko JM; Garrett JT; Kuba MG; Estrada MV; González-Angulo AM; Mills GB; Red-Brewer M; Mayer IA; Abramson V; Rizzo M; Kelley MC; Meszoely IM; Arteaga CL
    J Clin Invest; 2014 Dec; 124(12):5490-502. PubMed ID: 25401474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells.
    Rai D; Frolova A; Frasor J; Carpenter AE; Katzenellenbogen BS
    Mol Endocrinol; 2005 Jun; 19(6):1606-17. PubMed ID: 15831524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
    Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
    Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells.
    Yao C; Lin Y; Chua MS; Ye CS; Bi J; Li W; Zhu YF; Wang SM
    Int J Cancer; 2007 Nov; 121(9):1949-1957. PubMed ID: 17621625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells.
    Le Dily F; Métivier R; Guéguen MM; Le Péron C; Flouriot G; Tas P; Pakdel F
    Breast Cancer Res Treat; 2008 Jul; 110(1):69-83. PubMed ID: 17674191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
    Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
    Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testes-specific protease 50 promotes cell invasion and metastasis by increasing NF-kappaB-dependent matrix metalloproteinase-9 expression.
    Song ZB; Ni JS; Wu P; Bao YL; Liu T; Li M; Fan C; Zhang WJ; Sun LG; Huang YX; Li YX
    Cell Death Dis; 2015 Mar; 6(3):e1703. PubMed ID: 25811800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers.
    Ciucci A; Zannoni GF; Buttarelli M; Lisi L; Travaglia D; Martinelli E; Scambia G; Gallo D
    Oncotarget; 2016 Feb; 7(7):8155-71. PubMed ID: 26797759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.